Communication to the Court from the Registry dated 02-OCT-2013 re: Discontinuance - Trial JA advised that hearing date for 30-JUN-2014 should be vacated. Copy of discontinuance sent to Trial JA under cover of memo

Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc. 19 upon all parties by telecopier on 27-SEP-2013 filed on 27-SEP-2013

Discontinuance with Consent on behalf of Applicant with consent on behalf of Respondent filed on 27-SEP-2013

****** CANCELLED ****** Communication to the Court from the Registry dated 16-SEP-2013 re: motion doc # 12 sent to court for disposition

Order dated 13-SEP-2013 rendered by Martha Milczynski, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 12 Result: 1. The style of cause in this proceeding is hereby deemed amended to reflect the fact that the name of the respondent has changed from Cobalt to Actavis Pharma. ... Filed on 13-SEP-2013 entered in J. & O. Book, volume 1204 page(s) 368 - 369 Interlocutory Decision

Covering letter from Respondent, Cobalt Pharmaceuticals Company dated 12-SEP-2013 concerning Doc. No. 16 placed on file on 12-SEP-2013

Solicitor's certificate of service on behalf of Thomas Wong confirming service of Doc. 16 upon Applicant by personal service on 12-SEP-2013 confirming service Doc. 16 upon Respondent, the Minister of Health by personal service on 12-SEP-2013 filed on 12-SEP-2013

Motion Record containing the following original document(s): 12 13 14 15 Number of copies received: 3 on behalf of Respondent, Cobalt Pharmaceuticals Company filed on 12-SEP-2013

Written Representations contained within a Motion Record on behalf of Respondent, Cobalt Pharmaceuticals Company concerning Motion in writing Doc. No. 12 filed on 12-SEP-2013

Consent on behalf of all parties to Doc. 12 filed on 12-SEP-2013

Affidavit of Kathryn May sworn on 04-SEP-2013 contained within a Motion Record on behalf of Respondent in support of Motion Doc. No. 12 with Exhibits A filed on 12-SEP-2013

Notice of Motion contained within a Motion Record on behalf of Respondent, Cobalt Pharmaceuticals Company in writing to be dealt with in the Toronto local office for an Order amending the style of cause in this Application going forward to reflect recent name changes of the Respondent (Cobalt Pharmaceuticals Company has become Actavis Pharma Company); and other relief filed on 12-SEP-2013 Draft Order\\Judgment received.

Acknowledgment of Receipt received from Both parties by fax with respect to Doc. 11 placed on file on 11-SEP-2013

Order (time and place) dated 11-SEP-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 30-JUN-2014 to begin at 09:30 duration: 4d language: E Filed on 11-SEP-2013 cc's sent to parties entered in J. & O. Book, volume 1204 page(s) 220 - 220 Transmittal letters placed on file

Oral directions received from the Court: Martha Milczynski, Prothonotary dated 22-AUG-2013 directing that The schedule is amended such that: 1. September 16 - GSK's evidence on the issue of infringement and fact evidence on validity shall be served. 2. September 23 - Cobalt's evidence on validity and in response to the issue of infringement shall be served. placed on file on 22-AUG-2013

Communication to the Court from the Registry dated 01-AUG-2013 re: Requisition for hearing

Letter from Applicant dated 29-JUL-2013 expressing the need to have a hearing scheduled and a decision rendered in this application prior to the expiry of the patent in September 2014 received on 29-JUL-2013

Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc 9 upon Respondents by telecopier on 26-JUL-2013 filed on 26-JUL-2013

Requisition for hearing - Application from Applicants filed on 26-JUL-2013 Tariff Application or appeal - $50.00

Letter from Applicant dated 13-JUN-2013 writing with the consent of corporate Respondent, requesting an amendment to the date in item 1 of the schedule of the May 16, 2013 direction (July 22, 2013 from June 28, 2013) cc'd to all parties received on 13-JUN-2013

Oral directions received from the Court: Martha Milczynski, Prothonotary dated 14-JUN-2013 directing that The direction of May 16 is amended such that GSK's evidence on the issue of infringement and fact evidence on the issue of validity shall be served no later than July 22, 2013. placed on file on 14-JUN-2013

Copy of Letter from Norton Rose Fulbright Canada LLP / s.e.n.c.r.l., s.r.l. dated 13-MAY-2013. re: Change of company name. Copy placed on 62 files. placed on file on 29-MAY-2013 Original placed on Court File No. T-2022-89

Oral directions received from the Court: Martha Milczynski, Prothonotary dated 16-MAY-2013 directing that 1. June 28, 2013 - GSK's evidence on infringement and fact evidence will be served. 2. September 9, 2013 - Cobalt's evidence on the issue of validity and in response to the issue of infringement will be served. 3. November 25, 2013 - GSK's evidence in response to the issue of validity shall be served. 4. December 2, 2013 - Any advisory letter whether a R. 312 motion will be required. 5. December 9, 2013 - Any motion for reply evidence shall be served and filed. 6. December 16, 2013 - Any responding motion record for reply evidence shall be served and filed. 7. November 25, 2013 - GSK to file a requisition for hearing. 8. March 3, 2014 - Cross-examinations shall be completed. 9. April 15, 2014- GSK's application record shall be served and filed. 10. May 15, 2014 - Cobalt's application record shall be served and filed. placed on file on 16-MAY-2013

Communication to the Court from the Registry dated 14-MAY-2013 re: R's letter dated 13-MAY-2013

Letter from Respondent, Cobalt dated 13-MAY-2013 with jotin proposed time table (cc'd to all parties) received on 13-MAY-2013

Oral directions received from the Court: Martha Milczynski, Prothonotary dated 06-MAY-2013 directing that the parties shall provide a proposal for the remaining steps in this proceeding by may 13, 2013. placed on file on 06-MAY-2013

Solicitor's certificate of service on behalf of Thomas Wong confirming service of Doc 7 upon all parties by telecopier on 15-MAR-2013 filed on 15-MAR-2013

Notice of appearance on behalf of Cobalt Pharmaceuticals Company, Respondent filed on 15-MAR-2013

Service copy of Doc. No. 1 with proof of service upon Respondent on 11-MAR-2013 filed on 11-MAR-2013

Affidavit of service of James Adeney sworn on 13-MAR-2013 on behalf of Respondent - The Minster of Health confirming service of Doc. #4 upon Applicant Respondent, Cobalt Pharmaceuticals Company by courier on 13-MAR-2013 with Exhibits "A" filed on 13-MAR-2013

Notice of appearance on behalf of Respondent, The Minister of Health filed on 13-MAR-2013

Order dated 12-MAR-2013 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that prothonotary Martha Milczynski is assigned as Case Management Judge in this matter. Filed on 12-MAR-2013 copies sent to parties entered in J. & O. Book, volume 1186 page(s) 383 - 383 Interlocutory Decision

Affidavit of service of Norman Ng sworn on 10-MAR-2013 on behalf of Applicant confirming service of Doc. No. 1 upon respondent, Cobalt Pharmaceuticals by personal service on 08-MAR-2013 filed on 11-MAR-2013

Notice of application and 2 copies with regard to PM(NOC) Regulations s. 6 filed on 08-MAR-2013 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes